Authors: SUTSCH G KIOWSKI W YAN XW HUNZIKER P CHRISTEN S STROBEL W KIM JH RICKENBACHER P BERTEL O

Citation: G. Sutsch et al., SHORT-TERM ORAL ENDOTHELIN-RECEPTOR ANTAGONIST THERAPY IN CONVENTIONALLY TREATED PATIENTS WITH SYMPTOMATIC SEVERE CHRONIC HEART-FAILURE, Circulation, 98(21), 1998, pp. 2262-2268

Authors: KIOWSKI W SUETSCH G YAN XW STROBEL W RICKENBACHER P HUNZIKER P CHRISTEN S BERTEL O

Citation: W. Kiowski et al., NEUROHORMONAL EFFECTS OF ENDOTHELIN-1-RECEPTOR ANTAGONIST THERAPY IN PATIENTS WITH CHRONIC HEART-FAILURE, Circulation, 96(8), 1997, pp. 510-510

Authors: SUETSCH G CHRISTEN S YAN XW STROBEL W RICKENBACHER P HUNZIKER P BERTEL O KIOWSKI W

Citation: G. Suetsch et al., CLINICAL AND HEMODYNAMIC-EFFECTS OF AN ORALLY-ACTIVE ENDOTHELIN-1-RECEPTOR ANTAGONIST IN PATIENTS WITH REFRACTORY CHRONIC HEART-FAILURE, Circulation, 96(8), 1997, pp. 511-511

Authors: DRENT ML LARSSON I WILLIAMOLSSON T QUAADE F CZUBAYKO F VONBERGMANN K STROBEL W SJOSTROM L VANDERVEEN EA

Citation: Ml. Drent et al., ORLISTAT (RO-18-0647), A LIPASE INHIBITOR, IN THE TREATMENT OF HUMAN OBESITY - A MULTIPLE-DOSE STUDY, International journal of obesity, 19(4), 1995, pp. 221-226